Principal Investigator
Bradley Gampel
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240573
Clinical Trial Summary
A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647